Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI-CPTC initiative perspective-Reference-Cited by-同舟云学术

Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI-CPTC initiative perspective

Published:2010-11-22 Issue:12 Volume:4 Page:904-914
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Rodriguez Henry,Rivers Robert,Kinsinger Christopher,Mesri Mehdi,Hiltke Tara,Rahbar Amir,Boja Emily

Publisher

Wiley

Subject

Clinical Biochemistry

Reference55 articles.

1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Atkinson;Clin. Pharmacol. Ther.,2001

2. Moving cancer diagnostics from bench to bedside;Zhang;Trends Biotechnol.,2007

3. Candidate-based proteomics in the search for biomarkers of cardiovascular disease;Anderson;J. Physiol.,2005

4. The case for early detection;Etzioni;Nat. Rev. Cancer,2005

5. Protein biomarker discovery and validation: the long and uncertain path to clinical utility;Rifai;Nat. Biotechnol.,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Inflection Point in Cancer Protein Biomarkers: What was and What's Next;Molecular & Cellular Proteomics;2023-07

2. Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?;PROTEOMICS;2022-08-26

3. Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma;Scientific Reports;2019-02-26

4. Targeted Proteomics Comes to the Benchside and the Bedside: Is it Ready for Us?;BioEssays;2019-02

5. Clinical potential of mass spectrometry-based proteogenomics;Nature Reviews Clinical Oncology;2018-11-28